Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer
In Brief: Hammond Resigned As ACS Officer; Wykoff Slated To Direct FDA Special Populations Office
Cancer society, In Major Restructure, Forms New Executive Committee, Bylaws
Mass. Passes Tobacco Tax, ACS Lauds Victory Over Cigarette Industry
DCE To Provide $3.4 Mil. For Follow-Up Of DES Daughters; Board k’s Tw RFAs, Contracts
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- Pour a Scotch, we’re talking clinical trials and prediction markets
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial - Consumers are increasingly accessing U.S. News rankings of cancer hospitals via AI chatbots
2026 report shows no change in the top-five lineup - The Directors: New directors Herbst and Gius chart a future built on AI, collaboration, and rural access









